查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701275

美國遠端醫療監測市場規模、佔有率、趨勢分析報告（按部署模式、監測類型、最終用途、細分市場預測，2025 年至 2030 年）

U.S. Remote Therapeutic Monitoring Market Size, Share & Trends Analysis Report By Deployment Mode (Cloud & Web-based, On-premise), By Monitoring Type (Therapeutic Data, Non-Physiological Data), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國遠端醫療監測市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國遠端醫療監測市場預計到2030年將達到9.6981億美元，2025年至2030年期間的複合年成長率為17.2%。

日益關注資料分析和加強患者照護、有利的政府政策以及穿戴式和行動醫療設備的技術進步是推動市場成長的一些因素。

糖尿病、高血壓、心臟病和慢性呼吸系統疾病等慢性疾病負擔的增加是遠端醫療監測市場最重要的促進因素之一。管理這些疾病通常需要持續監測，而遠端醫療監測 (RTM) 可以即時追蹤關鍵健康指標。 RTM 提供遠端監控患者生命徵象和治療進展的解決方案，使慢性疾病的管理變得更加容易，減少就診次數並改善患者的治療效果。隨著患有慢性疾病的人口不斷成長，對管理這些疾病的遠端監控技術的需求也在成長。

此外，政府和健康保險公司也越來越認知到遠端監控技術在改善醫療保健方面的重要性。例如，醫療保險和醫療補助服務中心（CMS）擴大了遠端醫療監控服務的報銷政策，將慢性疾病患者的設備使用和護理協調納入其中。

此外，從按服務收費模式轉向基於價值的護理的轉變是影響遠端醫療監控 (RTM) 市場的一個主要因素。在基於價值的照護模式中，醫療保健提供者受到激勵，在盡量降低成本的同時提供優質照護。 RTM 透過使醫療保健提供者能夠遠端監控患者健康狀況、減少醫院再入院率和預防併發症來支持基於價值的護理，從而促進市場成長。例如，2025 年 1 月，Smart Pillbox 推出了 HealthBuddy 應用程式，以提高患者的用藥依從性。該應用程式透過向用戶提供藥物提醒和追蹤功能來支援治療監測。

美國遠端醫療監測市場報告重點

  • 根據部署模式，雲端基礎市場在 2024 年佔據了最大的市場佔有率，預計在 2025 年至 2030 年期間將以最快的複合年成長率成長。這種成長歸因於可訪問性的提高、即時資料能力、可擴展性、成本效益、提供者之間協作的改善以及強大的安全功能。
  • 根據監測類型，治療領域佔據了市場主導地位，佔據了 2024 年最大的收入佔有率。這是因為它能夠提高病人參與和依從性，實現即時監測和調整，並支援資料主導的決策流程。此外，治療資料有助於最佳化資源利用率，提高成本效益，符合旨在改善整體健康結果同時有效管理成本的基於價值的護理計劃。
  • 根據最終用途，醫療保健提供者部門預計將在 2024 年佔據最大的市場佔有率。醫療保健提供者是遠距患者照護、改善患者溝通、做出資料主導的決策、實現成本效益、受益於監管支持、確保護理的擴充性和可及性、有效地與現有系統整合以及專注於遠端醫療預防保健策略方面發揮著關鍵作用。
  • 根據最終用途，預計患者/看護者部分在預測期內將以最快的複合年成長率成長。
  • 2024 年 12 月，ElectronRx 宣布推出其 purpleDx 智慧型手機應用程式，旨在遠端監測肺部疾病患者的肺功能。該應用程式允許用戶追蹤他們的呼吸健康狀況並向醫療保健提供者提供即時資料。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國遠端醫療監測 (RTM) 市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 市場機會分析
  • 市場問題分析
  • 美國遠端醫療監控（RTM）市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
  • 案例研究
  • EHR 整合 RTM 解決方案
  • 法律規範

第4章美國遠端醫療監測 (RTM) 市場：部署模式評估與趨勢分析

  • 細分儀表板
  • 美國遠端醫療監測（RTM）市場、部署模式變化分析
  • 2018 年至 2030 年美國遠端醫療監測 (RTM) 市場規模及趨勢分析（依部署模式）
  • 基於雲端和 Web
  • 本地

第5章美國遠端醫療監測（RTM）市場：監測類型的估計和趨勢分析

  • 細分儀表板
  • 美國遠端醫療監測（RTM）市場、監測類型變化分析
  • 2018 年至 2030 年美國遠端醫療監測 (RTM) 市場規模及趨勢分析（依監測類型）
  • 治療資料
    • 藥物依從性
    • 對藥物的反應
  • 非生理資料

第6章美國遠端醫療監測 (RTM) 市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 美國遠端醫療監測 (RTM) 市場、最終用途差異分析
  • 2018 年至 2030 年美國遠端醫療監測 (RTM) 市場規模及趨勢分析（依最終用途）
  • 醫療保健提供者
    • 醫院
    • 專科診所
    • 復健中心
    • 療養院和長期照護機構
  • 家庭醫療保健
  • 患者和看護者
  • 付款人

第7章競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/列表
    • Zimmer Biomet
    • Medsien, Inc.
    • Adhere+Corporation
    • Academy Medtech Ventures
    • CircleLink Health Inc.
    • Limber Health, Inc.
    • HealthArc
    • Hero Health, Inc.
    • IncludeHealth Inc
    • Propeller Health（Resmed）
Product Code: GVR-4-68040-537-2

U.S. Remote Therapeutic Monitoring Market Growth & Trends:

The U.S. remote therapeutic monitoring market is anticipated to reach USD 969.81 million by 2030 and is anticipated to grow at a CAGR of 17.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing focus on enhanced data analytics and patient care, favorable government policies, and technological advancements in wearables and mobile health devices are some of the factors contributing to market growth.

The increasing burden of chronic diseases such as diabetes, hypertension, heart disease, and chronic respiratory conditions is one of the most significant driver of the remote therapeutic monitoring market. Managing these conditions often requires continuous monitoring, and remote therapeutic monitoring (RTM) allows for real-time tracking of key health metrics. RTM provides a solution to remotely monitor patients' vital signs and therapeutic progress, making it easier to manage chronic conditions, reduce hospital visits, and improve patient outcomes. As the population with chronic diseases continues to grow, the demand for remote monitoring technologies to manage these conditions is also increasing.

Furthermore, governments and health insurers are increasingly acknowledging the significance of remote monitoring technologies in improving healthcare delivery. For instance, the Centers for Medicare & Medicaid Services (CMS) have broadened reimbursement policies for remote therapeutic monitoring services, encompassing device utilization and care coordination for patients with chronic conditions.

Moreover, the transition from fee-for-service models to value-based care is a major factor influencing the remote therapeutic monitoring (RTM) market. In value-based care models, healthcare providers are encouraged to deliver high-quality care while minimizing costs. RTM supports value-based care by allowing healthcare providers to monitor patient health remotely, reduce hospital readmissions, and prevent complications, thereby contributing to market growth. For instance, in January 2025, Smart Pillbox launched the HealthBuddy app to enhance medication adherence for patients. This app supports therapeutic monitoring by providing users with medication reminders and tracking features.

U.S. Remote Therapeutic Monitoring Market Report Highlights:

  • Based on deployment mode, the web & cloud-based segment held the largest market share in 2024 and is expected to register growth at the fastest CAGR from 2025 to 2030. This growth can be attributed to its enhanced accessibility, real-time data capabilities, scalability, cost-effectiveness, improved collaboration among providers, and strong security features.
  • Based on monitoring type, therapeutic segment dominated the market and accounted for the largest revenue share in 2024, owing its ability to improve patient engagement and adherence, enable real-time monitoring and adjustments, and support data-driven decision-making processes. In addition, therapeutic data helps optimize resource utilization for cost-effectiveness and aligns with value-based care initiatives, which aim to improve overall health outcomes while managing costs efficiently.
  • Based on end use, the healthcare providers segment held the largest market share in 2024. Healthcare providers serve as significant end users in the remote therapeutic monitoring market due to their critical role in enhancing patient care through continuous monitoring, improving communication with patients, making data-driven decisions, achieving cost efficiencies, benefiting from regulatory support, ensuring scalability and accessibility of care, integrating with existing systems effectively, and focusing on preventive care strategies.
  • Based on end use, the patients & caregivers segment is expected to register growth at the fastest CAGR during the forecast period.
  • In December 2024, ElectronRx anounced to launch the purpleDx smartphone app, designed for remote monitoring of lung function in patients with pulmonary diseases. The app enables users to track their respiratory health, providing real-time data to healthcare providers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Deployment Mode
    • 1.2.2. Monitoring Type Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Remote Therapeutic Monitoring (RTM) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Wearables and Mobile Health Devices
      • 3.2.1.2. Integration of Artificial Intelligence (AI) and Machine Learning (ML)
      • 3.2.1.3. Growing preference for telemedicine and telehealth solutions
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data Security and privacy concerns
      • 3.2.2.2. High initial implementation costs
  • 3.3. Market Opportunity Analysis
  • 3.4. Market Challenges Analysis
  • 3.5. U.S. Remote Therapeutic Monitoring (RTM) Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
      • 3.5.2.4. Environmental Landscape
      • 3.5.2.5. Legal Landscape
      • 3.5.2.6. Social Landscape
  • 3.6. Case Study
  • 3.7. EHR Integrated RTM Solution
  • 3.8. Regulatory Framework

Chapter 4. U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment Mode Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Remote Therapeutic Monitoring (RTM) Market Deployment Mode Movement Analysis
  • 4.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by Deployment Mode, 2018 to 2030 (USD Million)
  • 4.4. Cloud & Web-based
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. On-premise
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Remote Therapeutic Monitoring Market Monitoring Type Movement Analysis
  • 5.3. U.S. Remote Therapeutic Monitoring Market Size & Trend Analysis, by Monitoring Type, 2018 to 2030 (USD Million)
  • 5.4. Therapeutic Data
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Therapy Medication Adherence
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Therapy Medication Response
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Non-Physiological Data
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Remote Therapeutic Monitoring (RTM) Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Remote Therapeutic Monitoring (RTM) Market End Use Movement Analysis
  • 6.3. U.S. Remote Therapeutic Monitoring (RTM) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Healthcare Providers
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Hospitals
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Specialty Clinics
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Rehabilitation Centers
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Nursing Homes & Long-Term Care Facilities
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Home Healthcare
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Patients & Caregivers
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Payers
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Zimmer Biomet
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Medsien, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Adhere+ Corporation
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Academy Medtech Ventures
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. CircleLink Health Inc.
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Limber Health, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. HealthArc
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Hero Health, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. IncludeHealth Inc
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Propeller Health (Resmed)
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of secondary sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Remote Therapeutic Monitoring (RTM) Market: Market outlook
  • Fig. 5 U.S. Remote Therapeutic Monitoring (RTM) Market: Segment outlook
  • Fig. 6 U.S. Remote Therapeutic Monitoring (RTM) Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Remote Therapeutic Monitoring (RTM) Market driver impact
  • Fig. 9 U.S. Remote Therapeutic Monitoring (RTM) Market restraint impact
  • Fig. 10 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode outlook and key takeaways
  • Fig. 11 U.S. Remote Therapeutic Monitoring (RTM) Market: Deployment mode movement analysis
  • Fig. 12 Cloud & Web-based market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 13 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type outlook and key takeaways
  • Fig. 15 U.S. Remote Therapeutic Monitoring (RTM) Market: Monitoring Type movement analysis
  • Fig. 16 Therapeutic data market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Non-physiological data market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use outlook and key takeaways
  • Fig. 19 U.S. Remote Therapeutic Monitoring (RTM) Market: End Use movement analysis
  • Fig. 20 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Home healthcare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Patients & caregivers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Payers market estimates and forecast, 2018 - 2030 (USD Million)